COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 190 filers reported holding COHERUS BIOSCIENCES INC in Q2 2021. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,599,170 | +5.9% | 962,345 | +20.9% | 0.00% | 0.0% |
Q2 2023 | $3,399,932 | -34.9% | 796,237 | +4.3% | 0.00% | 0.0% |
Q1 2023 | $5,223,490 | -12.2% | 763,668 | +1.7% | 0.00% | 0.0% |
Q4 2022 | $5,948,078 | -18.3% | 751,020 | -0.8% | 0.00% | -50.0% |
Q3 2022 | $7,277,000 | +34.6% | 757,124 | +1.4% | 0.00% | +100.0% |
Q2 2022 | $5,407,000 | -40.6% | 746,844 | +5.9% | 0.00% | -50.0% |
Q1 2022 | $9,104,000 | -22.0% | 705,200 | -3.5% | 0.00% | 0.0% |
Q4 2021 | $11,668,000 | -2.0% | 731,102 | -1.4% | 0.00% | 0.0% |
Q3 2021 | $11,912,000 | +13.3% | 741,234 | -2.5% | 0.00% | 0.0% |
Q2 2021 | $10,516,000 | -0.1% | 760,409 | +5.5% | 0.00% | 0.0% |
Q1 2021 | $10,531,000 | -19.8% | 720,775 | -4.6% | 0.00% | -33.3% |
Q4 2020 | $13,136,000 | -7.4% | 755,823 | -2.3% | 0.00% | 0.0% |
Q3 2020 | $14,191,000 | -1.8% | 773,746 | -4.4% | 0.00% | 0.0% |
Q2 2020 | $14,454,000 | +14.2% | 809,305 | +3.7% | 0.00% | -25.0% |
Q1 2020 | $12,661,000 | -9.7% | 780,594 | +0.3% | 0.00% | +33.3% |
Q4 2019 | $14,019,000 | -12.6% | 778,631 | -1.6% | 0.00% | -25.0% |
Q3 2019 | $16,031,000 | +4.2% | 791,226 | +13.6% | 0.00% | 0.0% |
Q2 2019 | $15,392,000 | +69.8% | 696,453 | +4.8% | 0.00% | +100.0% |
Q1 2019 | $9,065,000 | +54.0% | 664,619 | +2.2% | 0.00% | 0.0% |
Q4 2018 | $5,888,000 | -46.0% | 650,544 | -1.6% | 0.00% | -33.3% |
Q3 2018 | $10,910,000 | +37.5% | 661,168 | +16.7% | 0.00% | +50.0% |
Q2 2018 | $7,934,000 | +50.4% | 566,700 | +18.7% | 0.00% | +100.0% |
Q1 2018 | $5,274,000 | +27.9% | 477,300 | +1.9% | 0.00% | 0.0% |
Q4 2017 | $4,124,000 | -34.1% | 468,540 | -0.0% | 0.00% | -50.0% |
Q3 2017 | $6,256,000 | -6.1% | 468,668 | +1.0% | 0.00% | 0.0% |
Q2 2017 | $6,660,000 | -22.8% | 464,056 | +13.8% | 0.00% | 0.0% |
Q1 2017 | $8,628,000 | -14.2% | 407,934 | +14.2% | 0.00% | -33.3% |
Q4 2016 | $10,055,000 | -0.7% | 357,191 | -5.5% | 0.00% | 0.0% |
Q3 2016 | $10,123,000 | +66.0% | 378,017 | +4.7% | 0.00% | +50.0% |
Q2 2016 | $6,099,000 | +7.1% | 361,095 | +34.1% | 0.00% | 0.0% |
Q1 2016 | $5,695,000 | -7.0% | 269,180 | +0.9% | 0.00% | 0.0% |
Q4 2015 | $6,124,000 | +17.8% | 266,732 | +2.8% | 0.00% | 0.0% |
Q3 2015 | $5,199,000 | +67.0% | 259,396 | +140.8% | 0.00% | +100.0% |
Q2 2015 | $3,114,000 | +13.0% | 107,715 | +19.6% | 0.00% | 0.0% |
Q1 2015 | $2,755,000 | +141.2% | 90,098 | +28.7% | 0.00% | – |
Q4 2014 | $1,142,000 | – | 69,989 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
Knott David M Jr | 630,000 | $2,356 | 0.90% |
COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |